期刊文献+

反义寡核苷酸药代动力学研究中的定量分析技术 被引量:1

Quantitative bioanalytical methods for pharmacokinetics of antisense oligonucleotides
下载PDF
导出
摘要 反义寡核苷酸药物的药代动力学研究要求具备相应的生物定量方法。本文就近年来在临床前和临床药代动力学评价中常用的几种定量方法,包括放射性同位素法、毛细管凝胶电泳法、高效液相色谱法、液质联用和基于杂交技术的酶联免疫法,对其各自的特性、应用前景、操作方法及局限性等方面进行了综述。 The pharmacokinetic researches of antisense therapeutic agents require the development of a number of bioanalytical methods for their quantitation. Recently, the most common bioanalytical techniques used in preclinical and clinical pharmacokinetic assessment include radiotracer methods, CGE with UV detection or with LIF detection, HPLC, LC-MS/MS, and hybridization-based ELISA. Their specific features, application prospects, characteristics of operation and limitations are summarized in this review.
出处 《国外医学(药学分册)》 2007年第1期17-20,共4页 Foreign Medical Sciences(Section of Pharmarcy)
基金 国家科技攻关项目(2004BA519A35)
关键词 反义寡核苷酸 生物定量方法 药代动力学 antisense oligonucleotide, bioanalytical method, pharmacokinetics
  • 相关文献

参考文献29

  • 1Braasch DA, Corey DR. Novel anfisense and pepfide nucleic acid strategies for controlling gene expression [ J ]. Biochemistry,2002, 41 (14) :4503 -4510.
  • 2Levin AA. A review of issues in the pharmacokinefics and toxicology of phosphorothioate anfisense oligonucleofides [ J ]. Biochim Biophys Acta, 1999, 1489(1) :69 -84.
  • 3McKay RA, Miraglia LJ, Cummins EL, et al. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression [ J ]. J Biol Chem,1999, 274(3) :1715 - 1722.
  • 4Krupp JL, Bernards CM. Pharmacokinefics of intrathecal oligodeoxynucleotides[J]. Anesthesiology, 2004, 100(2) :315 -322.
  • 5Van Oekelen D, Megens A, Meert T, et al. Functional study of rat 5-HT2A receptors using anfisense oligonucleofides [J]. J Neurochem, 2003, 85(5) :1087 - 1100.
  • 6Ali S, Leonard SA, Kukoly CA, et al. Absorption, distribution,metabolism, and excretion of a respirable antisense oligonucleotide for asthma[J]. Am J Respir Crit Care Med, 2001, 163(4) :989 - 993.
  • 7Lopes de Menezes DE, Mayer LD. Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts[J]. Cancer Chemother Pharmacol, 2002, 49( 1 ) :57 -68.
  • 8Graham MJ, Crooke ST, Monteith DK, et al. In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration [ J ]. J Pharmacol Exp Ther ,1998, 286( 1 ) :447 -458.
  • 9Younes CK, Biosgrard R, Tavitian B. Labelled oligonucleotides as radiophannaceuticals : pitfalls, problems and perspectives [ J ].Curr Pharm Des, 2002, 8(16) :1451 - 1466.
  • 10Geary RS, Yu RZ, Watanabe T, et al. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-0-( 2-methoxyethyl) modified antisense oligonucleotide: comparison across species[J]. Drug Metab Dispos, 2003, 31 ( 11 ) : 1419 - 1428.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部